🧪 The UCL Genetics Society Journal Club continues!
Join us for our second session of the year with Mr. Sean Briggs, Research Assistant in Genetics and Genomic Medicine at the UCL Great Ormond Street Institute of Child Health.
Mr. Briggs will introduce antisense oligonucleotides (ASOs), a therapeutic approach that targets genetic disease at the mRNA level, and outline both advances and challenges in the field. He will then discuss his work on developing a targeted ASO delivery system using peptide conjugates to treat collagen VI-related congenital muscular dystrophies (COL6-CMD). This group of muscular dystrophies, caused by mutations in the three genes encoding the collagen VI protein, is characterised by progressive muscle weakness from birth or early childhood and currently has no available cure.
Here’s what you can expect!
- Hear first-hand from a UCL researcher about his cutting-edge work
- Learn more about nucleic acid therapies and genetic medicine, approaches with the potential to tackle conditions once thought to be untreatable
- Ask your questions on research and careers in academia during our Q&A session - a unique opportunity to network and gain advice
🧬 This event is part of our October Journal Club theme Gene and Nucleic Acid Therapies, the first in a series of monthly themes designed to give you broad introductions to key areas of genetics. Look forward to a new Journal Club session every two weeks throughout the year, each led by inspiring researchers from UCL and beyond.
⚠️ Please note that booking priority for this event is given to paid GenSoc members. If you only have a Taster membership, booking will open to you 7 days before the event (i.e., October 14th).